From the 1Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR
2St Luke's Clinic—Urogynecology, Boise, ID
3Division of Urogynecology, Department of Obstetrics and Gynecology, Oregon Health and Science University, and Kaiser Permanente Center for Health Research, Portland, OR.
Received October 11, 2022; revised and accepted December 12, 2022.
This paper was presented at the virtual 87th annual meeting of the Pacific Coast Obstetrical and Gynecological Society, September 2020.
Funding/support: The Patty Brisben Family Foundation for Women's Sexual Health, The National Vulvodynia Association, and private donations through the OHSU Foundation. Endocrine laboratory testing was supported by NIH Grant P51 OD011092, awarded to the Oregon National Primate Research Center.
Clinical trial registration: Clinicaltrials.gov NCT03240081.
Financial disclosure/conflicts of interest: A.L.C.: Legal Consultant Butler Snow LLC for Ethicon regarding pelvic mesh litigation and Hart Wagner LLC for general malpractice; member of the Provider Executive Group for Ms. Medicine LLC; Pfizer Grants for Independent Learning and Change for research about menopause education to residents. The other authors have none reported.
Supplemental digital content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s Website (www.menopause.org).
Address correspondence to: Martha F. Goetsch, MD, MPH, Department of Obstetrics and Gynecology, OHSU UHN50, 3181 SW Sam Jackson Park Road, Portland, OR, 97239. E-mail: [email protected]